Business Context and Reporting Period
This Form 8-K Current Report from Aptevo Therapeutics Inc. (APVO) covers the event date of December 3, 2024. The filing details the implementation of a reverse stock split of the Company's common stock, effective at 5:01 p.m. Eastern Time on December 3, 2024.
Key Financial Metrics
This filing does not contain financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity metrics. The document focuses exclusively on corporate governance and capital structure adjustments.
Material Changes
- Reverse Stock Split Execution: The Company effected a 1-for-37 reverse stock split. Every 37 shares of issued and outstanding common stock were automatically combined into one share.
- Trading Adjustments: Common stock began trading on The Nasdaq Capital Market on a split-adjusted basis on December 4, 2024, under the new CUSIP number 03835L 405.
- Equity Instrument Adjustments: Proportionate adjustments were made to the exercise prices and share counts of outstanding stock options, restricted stock units, and warrants. The number of shares reserved for issuance under equity compensation plans was reduced proportionately.
- Fractional Shares: No fractional shares were issued; holders entitled to fractional shares received cash payments in lieu thereof. Warrant exercise fractions were rounded up to the next whole share.
Guidance, Outlook, and Risks
The filing includes standard forward-looking statements regarding the reverse stock split, noting that actual results may differ due to risks such as delays in regulatory approvals. The Company disclaims any obligation to update these statements. No specific financial guidance or management commentary on operational outlook is provided in this document.
Investor Verification Checklist
- Verify the new CUSIP number (03835L 405) for trading purposes.
- Confirm the adjusted exercise prices and share counts for any held stock options, RSUs, or warrants.
- Check for cash payments received in lieu of fractional shares if applicable.
- Review the Company's subsequent filings for updated share count and capitalization tables.